Ben Mumford is a licensing manager in Memorial Sloan Kettering Cnacer Center’s Office of Technology Development (OTD). He is a member of OTD’s Technology Management & Commercialization group.
Prior to joining MSK in 2021, Ben was a research associate at several biotechnology firms, including Cellectis’ Immuno-oncology innovation group; Inzen Therapeutics’ Platform Development team; EpiBone’s pre-clinical development group; and Nomocan Pharmaceutical’s pre-clinical research team.
Ben received an M.S. in Biotechnology from New York University and holds a B.S. in Biochemistry from the University of Kansas.